Candriam Equities L Oncology Impact I Fonds
29.335,00
JPY
-511,00
JPY
-1,71
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| AstraZeneca PLC | GB0009895292 | 5,69% |
| Merck & Co Inc | US58933Y1055 | 5,55% |
| Novartis AG Registered Shares | CH0012005267 | 5,09% |
| Roche Holding AG | CH0012032048 | 5,03% |
| Eli Lilly and Co | US5324571083 | 5,01% |
| Siemens Healthineers AG Registered Shares | DE000SHL1006 | 4,55% |
| Novo Nordisk A/S Class B | DK0062498333 | 4,18% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,98% |
| Hologic Inc | US4364401012 | 3,76% |
| Gilead Sciences Inc | US3755581036 | 3,37% |
| Sonstige | 53,79% |